Literature DB >> 20572032

Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program.

Lori M Minasian1, William R Carpenter, Bryan J Weiner, Darrell E Anderson, Worta McCaskill-Stevens, Stefanie Nelson, Cynthia Whitman, Joseph Kelaghan, Ann M O'Mara, Arnold D Kaluzny.   

Abstract

The recent rapid acceleration of basic science is reshaping both our clinical research system and our healthcare delivery system. The pace and growing volume of medical discoveries are yielding exciting new opportunities, yet we continue to face old challenges to maintain research progress and effectively translate research into practice. The National Institutes of Health and individual government programs increasingly are emphasizing research agendas that involve evidence development, comparative-effectiveness research among heterogeneous populations, translational research, and accelerating the translation of research into evidence-based practice as well as building successful research networks to support these efforts. For more than 25 years, the National Cancer Institute Community Clinical Oncology Program has successfully extended research into the community and facilitated the translation of research into evidence-based practice. By describing its keys to success, this article provides practical guidance to cancer-focused, provider-based research networks as well as those in other disciplines.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20572032      PMCID: PMC2945622          DOI: 10.1002/cncr.25248

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  47 in total

1.  Disseminating innovations in health care.

Authors:  Donald M Berwick
Journal:  JAMA       Date:  2003-04-16       Impact factor: 56.272

2.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

3.  Translational and clinical science--time for a new vision.

Authors:  Elias A Zerhouni
Journal:  N Engl J Med       Date:  2005-10-12       Impact factor: 91.245

4.  A state-of-the-art conference on implementing evidence in health care. Reasons and recommendations.

Authors:  Catarina I Kiefe; Anne Sales
Journal:  J Gen Intern Med       Date:  2006-02       Impact factor: 5.128

5.  The practice-based research network as a model for end-of-life care research: challenges and opportunities.

Authors:  Jean S Kutner; Deborah S Main; John M Westfall; Wilson Pace
Journal:  Cancer Control       Date:  2005-07       Impact factor: 3.302

6.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

7.  Current NCI-sponsored Cooperative Group trials of endocrine therapies in breast cancer.

Authors:  Jennifer Eng-Wong; Jo Anne Zujewski
Journal:  Cancer       Date:  2008-02-01       Impact factor: 6.860

8.  Strategic approaches to cancer control research in NCI-funded research bases.

Authors:  M M McKinney; R B Warnecke; A D Kaluzny
Journal:  Cancer Detect Prev       Date:  1992

9.  Central challenges facing the national clinical research enterprise.

Authors:  Nancy S Sung; William F Crowley; Myron Genel; Patricia Salber; Lewis Sandy; Louis M Sherwood; Stephen B Johnson; Veronica Catanese; Hugh Tilson; Kenneth Getz; Elaine L Larson; David Scheinberg; E Albert Reece; Harold Slavkin; Adrian Dobs; Jack Grebb; Rick A Martinez; Allan Korn; David Rimoin
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

10.  Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.

Authors:  A D Kaluzny; L M Lacey; R Warnecke; D M Hynes; J Morrissey; L Ford; E Sondik
Journal:  Health Serv Res       Date:  1993-06       Impact factor: 3.402

View more
  49 in total

1.  Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults.

Authors:  Christina D Mack; William Carpenter; Anne-Marie Meyer; Hanna Sanoff; Til Stürmer
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

2.  Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).

Authors:  Ellen R Gritz; Kathryn B Arnold; Carol M Moinpour; Allison M Burton-Chase; Catherine M Tangen; Jeffrey F Probstfield; William A See; Michael M Lieber; Vincent Caggiano; Sarah Moody-Thomas; Connie Szczepanek; Anne Ryan; Susie Carlin; Shannon Hill; Phyllis J Goodman; Rose Mary Padberg; Lori M Minasian; Frank L Meyskens; Ian M Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-15       Impact factor: 4.254

3.  Next steps to improve disparities in lung cancer treatment clinical trial enrollment.

Authors:  Leah L Zullig; William R Carpenter; Christina D Williams
Journal:  Ann Transl Med       Date:  2017-03

4.  Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.

Authors:  Sara R Jacobs; Bryan J Weiner; Lori M Minasian; Marjorie J Good
Journal:  Contemp Clin Trials       Date:  2013-01-05       Impact factor: 2.226

5.  Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.

Authors:  William R Carpenter; Alice K Fortune-Greeley; Leah L Zullig; Shoou-Yih Lee; Bryan J Weiner
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

6.  The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation.

Authors:  William R Carpenter; Katherine Reeder-Hayes; John Bainbridge; Anne-Marie Meyer; Keith D Amos; Bryan J Weiner; Paul A Godley
Journal:  Med Care       Date:  2011-02       Impact factor: 2.983

7.  A method for analyzing the business case for provider participation in the National Cancer Institute's Community Clinical Oncology Program and similar federally funded, provider-based research networks.

Authors:  Kristin L Reiter; Paula H Song; Lori Minasian; Marjorie Good; Bryan J Weiner; Ann Scheck McAlearney
Journal:  Cancer       Date:  2011-12-27       Impact factor: 6.860

8.  Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation.

Authors:  William R Carpenter; Anne-Marie Meyer; Yang Wu; Bahjat Qaqish; Hanna K Sanoff; Richard M Goldberg; Bryan J Weiner
Journal:  Med Care       Date:  2012-08       Impact factor: 2.983

9.  Challenges and facilitators of community clinical oncology program participation: a qualitative study.

Authors:  Ann Scheck McAlearney; Kristin L Reiter; Bryan J Weiner; Lori Minasian; Paula H Song
Journal:  J Healthc Manag       Date:  2013 Jan-Feb

10.  The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.

Authors:  Paula H Song; Kristin L Reiter; Bryan J Weiner; Lori Minasian; Ann Scheck McAlearney
Journal:  Health Care Manage Rev       Date:  2013 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.